Montag & Associates’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.9K | Hold |
6
| – | – | ﹤0.01% | 848 |
|
|
2025
Q1 | $1.57K | Hold |
6
| – | – | ﹤0.01% | 913 |
|
|
2024
Q4 | $1.37K | Buy |
6
+1
| +20% | +$228 | ﹤0.01% | 918 |
|
|
2024
Q3 | $1.35K | Hold |
5
| – | – | ﹤0.01% | 946 |
|
|
2024
Q2 | $1.19K | Hold |
5
| – | – | ﹤0.01% | 915 |
|
|
2024
Q1 | $733 | Sell |
5
-2
| -29% | -$293 | ﹤0.01% | 947 |
|
|
2023
Q4 | $1.34K | Hold |
7
| – | – | ﹤0.01% | 872 |
|
|
2023
Q3 | $1.24K | Hold |
7
| – | – | ﹤0.01% | 859 |
|
|
2023
Q2 | $1.33K | Hold |
7
| – | – | ﹤0.01% | 871 |
|
|
2023
Q1 | $1.4K | Hold |
7
| – | – | ﹤0.01% | 870 |
|
|
2022
Q4 | $1.66K | Buy |
+7
| New | +$1.66K | ﹤0.01% | 876 |
|